BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31235932)

  • 1. TREM2 function impedes tau seeding in neuritic plaques.
    Leyns CEG; Gratuze M; Narasimhan S; Jain N; Koscal LJ; Jiang H; Manis M; Colonna M; Lee VMY; Ulrich JD; Holtzman DM
    Nat Neurosci; 2019 Aug; 22(8):1217-1222. PubMed ID: 31235932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
    Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated microglia mitigate Aβ-associated tau seeding and spreading.
    Gratuze M; Chen Y; Parhizkar S; Jain N; Strickland MR; Serrano JR; Colonna M; Ulrich JD; Holtzman DM
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34100905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
    Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
    Gratuze M; Leyns CE; Sauerbeck AD; St-Pierre MK; Xiong M; Kim N; Serrano JR; Tremblay MÈ; Kummer TT; Colonna M; Ulrich JD; Holtzman DM
    J Clin Invest; 2020 Sep; 130(9):4954-4968. PubMed ID: 32544086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
    Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
    Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.
    Yuan P; Condello C; Keene CD; Wang Y; Bird TD; Paul SM; Luo W; Colonna M; Baddeley D; Grutzendler J
    Neuron; 2016 May; 90(4):724-39. PubMed ID: 27196974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
    Wang Y; Ulland TK; Ulrich JD; Song W; Tzaferis JA; Hole JT; Yuan P; Mahan TE; Shi Y; Gilfillan S; Cella M; Grutzendler J; DeMattos RB; Cirrito JR; Holtzman DM; Colonna M
    J Exp Med; 2016 May; 213(5):667-75. PubMed ID: 27091843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology.
    Wood JI; Wong E; Joghee R; Balbaa A; Vitanova KS; Stringer KM; Vanshoiack A; Phelan SJ; Launchbury F; Desai S; Tripathi T; Hanrieder J; Cummings DM; Hardy J; Edwards FA
    Cell Rep; 2022 Nov; 41(8):111686. PubMed ID: 36417868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading.
    Jain N; Lewis CA; Ulrich JD; Holtzman DM
    J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36219197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
    Ulrich JD; Holtzman DM
    ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trem2
    Tran KM; Kawauchi S; Kramár EA; Rezaie N; Liang HY; Sakr JS; Gomez-Arboledas A; Arreola MA; Cunha CD; Phan J; Wang S; Collins S; Walker A; Shi KX; Neumann J; Filimban G; Shi Z; Milinkeviciute G; Javonillo DI; Tran K; Gantuz M; Forner S; Swarup V; Tenner AJ; LaFerla FM; Wood MA; Mortazavi A; MacGregor GR; Green KN
    Mol Neurodegener; 2023 Feb; 18(1):12. PubMed ID: 36803190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
    McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
    Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo.
    Lee-Gosselin A; Jury-Garfe N; You Y; Dabin L; Soni D; Dutta S; Rochet JC; Kim J; Oblak AL; Lasagna-Reeves CA
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
    Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
    Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2: Keeping Microglia Fit during Good Times and Bad.
    Hong S; Stevens B
    Cell Metab; 2017 Oct; 26(4):590-591. PubMed ID: 28978423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.